13F-HR filed by Boxer Capital, LLC
Boxer Capital, LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 24 holding rows worth $809,378,000.
- Accession
- 0000950123-19-002250
- Filer
- CIK 1465837
- Filed
- 2019-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2018
A holdings report, 24 entries on the cover page, a total value of $809,378,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $809,378,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 900,000 | $126,234,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 3,498,272 | $93,754,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 2,155,000 | $73,960,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,650,000 | $69,366,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,565,560 | $66,411,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 600,000 | $60,474,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,200,000 | $55,200,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 2,978,762 | $41,941,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 1,200,000 | $34,584,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,966,051 | $29,137,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 4,500,000 | $28,890,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 700,000 | $28,735,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,500,000 | $20,415,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,094,000 | $16,480,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,150,000 | $16,411,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 844,789 | $11,861,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 290,577 | $8,162,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 2,913,091 | $7,691,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NE | 29664W905 | COM | 100,000 | $4,600,000 | thousands by filing date | call |
| MEDICINES CO | 584688105 | COM | 232,000 | $4,440,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 200,000 | $3,950,000 | thousands by filing date | |
| MATINAS BIOPHARMA HLDGS INC | 576810105 | COM | 5,642,858 | $3,358,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 50,000 | $2,805,000 | thousands by filing date | |
| NOVUS THERAPEUTICS INC | 67011N105 | COM | 324,383 | $519,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-19-002250 | this filing | 2019-02-14 | acceptance time not in the bulk data set |